Lenalidomide induces apoptosis and alters gene expression in non-small cell lung cancer cells

Non-small cell lung cancer (NSCLC) is the most deadly type of cancer worldwide. Although a number of therapies are used in NSCLC treatment, their therapeutic efficacy remains low. Lenalidomide was originally approved for use in patients with myelodysplastic syndromes, which are associated with 5q de...

Descripción completa

Detalles Bibliográficos
Autores principales: KIM, KARAM, AN, SUNGKWAN, CHA, HWA JUN, CHOI, YEONG MIN, CHOI, SUNG JIN, AN, IN-SOOK, LEE, HONG GHI, MIN, YOO HONG, LEE, SU-JAE, BAE, SEUNGHEE
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573063/
https://www.ncbi.nlm.nih.gov/pubmed/23420263
http://dx.doi.org/10.3892/ol.2012.1054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573063/
https://www.ncbi.nlm.nih.gov/pubmed/23420263
http://dx.doi.org/10.3892/ol.2012.1054

Ejemplares similares